My first week at 23andMe, the Wall Street Journal declared the company was worth “nearly $0.” By the time I left, a little more than a year later, the company had filed for bankruptcy.
As a board-certified genetic counselor, I believe that genetic information can empower healthier decisions. I joined 23andMe because I believed in the company’s mission: giving people access to their genetic information. I still do. But belief alone couldn’t save 23andMe, and only time will tell if 23andMe’s bankruptcy is a harbinger of consumer genomics’ death altogether.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.